-
The "Disaster Preparedness for Dementia Caregivers" guide has advice in plain language about planning for storms, addresses the risk of wandering and offers strategies for reducing anxiety.
-
The Food and Drug Administration is expected to grant full approval to the Alzheimer's drug lecanemab by July 6. But access to the drug may still be limited.
-
One Clearwater woman says caring for her wife with Alzheimer's disease wouldn't be possible without help from a "tribe" of friends and community services.
-
Families can get blindsided by risky behavior with money, sometimes even before a diagnosis. Having tough conversations and setting up guardrails in advance can help prevent disaster.
-
The Supreme Court ruled for the family of a nursing home resident with dementia that had sued over his care, declining to use the case to broadly limit the right to sue government workers.
-
The announcement comes less than four months after former President Jimmy Carter entered hospice care at the couple's home in Plains, Ga., following several stints in and out of the hospital.
-
Reckless behavior with money can be a warning sign of cognitive decline — and the condition can put people at risk of financial ruin. There are few institutional safeguards in place.
-
In the 18-month trial, people in the early stages of Alzheimer's who received infusions of donanemab showed 35% less decline in thinking skills compared to those given a dummy drug, Lilly announced.
-
Lessons learned in a Mayo Clinic study could lead to treatment or even a cure for Alzheimer's.
-
The AHEAD Study - with participants in the Orlando region - examines whether the newly approved drug lecanemab can prevent or at least delay the appearance of Alzheimer's symptoms.